A New Insight into Meloxicam: Assessment of Antioxidant and Anti-Glycating Activity in In Vitro Studies

Meloxicam is a non-steroidal anti-inflammatory drug, which has a preferential inhibitory effect to cyclooxyganase-2 (COX-2). Although the drug inhibits prostaglandin synthesis, the exact mechanism of meloxicam is still unknown. This is the first study to assess the effect of meloxicam on protein gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlukianiec, Cezary, Gryciuk, Małgorzata Ewa, Mil, Kacper Maksymilian, Żendzian-Piotrowska, Małgorzata, Zalewska, Anna, Maciejczyk, Mateusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558080/
https://www.ncbi.nlm.nih.gov/pubmed/32927809
http://dx.doi.org/10.3390/ph13090240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558080/
https://www.ncbi.nlm.nih.gov/pubmed/32927809
http://dx.doi.org/10.3390/ph13090240

Ejemplares similares